$0.77
-0.03 (-4.12%)
Open$0.80
Previous Close$0.80
Day High$0.85
Day Low$0.77
52W High$2.10
52W Low$0.66
Volume—
Avg Volume254.4K
Market Cap171.06M
P/E Ratio0.14
EPS$9.85
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+4,672.7% upside
Current
$0.77
$0.77
Target
$36.75
$36.75
$26.33
$36.75 avg
$40.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 40.60M | 42.46M | 39.37M |
| Net Income | -1,409,045 | -1,565,662 | -1,719,749 |
| Profit Margin | -3.5% | -3.7% | -4.4% |
| EBITDA | -2,559,719 | -2,552,246 | -2,827,370 |
| Free Cash Flow | -1,137,405 | -963,691 | -1,418,550 |
| Rev Growth | +15.5% | -1.3% | +12.3% |
| Debt/Equity | 0.48 | 0.77 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |